2021
DOI: 10.3390/photonics8010022
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of Glioma Molecular Markers by Terahertz Technologies

Abstract: This review considers glioma molecular markers in brain tissues and body fluids, shows the pathways of their formation, and describes traditional methods of analysis. The most important optical properties of glioma markers in the terahertz (THz) frequency range are also presented. New metamaterial-based technologies for molecular marker detection at THz frequencies are discussed. A variety of machine learning methods, which allow the marker detection sensitivity and differentiation of healthy and tumor tissues… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 204 publications
(243 reference statements)
0
17
0
Order By: Relevance
“…Glioma is one of the most common tumors in the central nervous system [1]. Its identification at the earliest stages is a medical task of primary importance [2]. Among molecular biomarkers of gliomas, the mutated enzyme of isocitrate dehydrogenase 1/2 (IDH1/IDH2) was recently identified [3].…”
Section: Introductionmentioning
confidence: 99%
“…Glioma is one of the most common tumors in the central nervous system [1]. Its identification at the earliest stages is a medical task of primary importance [2]. Among molecular biomarkers of gliomas, the mutated enzyme of isocitrate dehydrogenase 1/2 (IDH1/IDH2) was recently identified [3].…”
Section: Introductionmentioning
confidence: 99%
“…An increasing interest in biomedical applications of terahertz (THz) radiation, featuring the frequencies of 0.1 to 3.0 THz, the free-space wavelengths of to , or the quantum energies of to 10 meV (see Fig. 1 ), has been observed during the past few decades, 1 5 driven by rapid progress in THz technology. 6 , 7 Numerous research papers demonstrate the potential of THz technology in label-free early noninvasive, least-invasive, and intraoperative diagnosis of malignant and benign neoplasms with different nosologies and localizations, 3 , 4 , 8 18 sensing of glycated tissues and blood in the context of diabetes diagnosis, 1 , 19 21 determining the degree of traumatic injuries, 22 25 hydration levels, 26 29 and viability 30 of tissues.…”
Section: Introductionmentioning
confidence: 99%
“…The assessment of all these biochemical compounds makes it possible to differentiate between normal and pathological tissues of the brain, as well as between different stages of a pathological process relying on the THz spectra and images. All these factors, along with the biochemical and structural neuronal and glial features, including microscopic variations of tissue properties (tissue microenvironments 34 , cellular and tissue morphology 35 , biomolecules 36 and their large-scale fluctuations 25,37 ), make the brain an exciting subject for study using THz technology 10,38,39 .…”
mentioning
confidence: 99%